Provided by Tiger Trade Technology Pte. Ltd.

Silence Therapeutics Plc

10.64
-0.0700-0.65%
Post-market: 10.660.0150+0.14%19:30 EDT
Volume:973.33K
Turnover:10.31M
Market Cap:661.32M
PE:-8.38
High:10.78
Open:10.77
Low:10.38
Close:10.71
52wk High:17.58
52wk Low:4.19
Shares:62.15M
Float Shares:50.17M
Volume Ratio:0.89
T/O Rate:1.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2693
EPS(LYR):-1.8761
ROE:-90.41%
ROA:-29.65%
PB:17.19
PE(LYR):-5.67

Loading ...

Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Oct 23, 2025

Major Issues Report

Form 8-K - Current report
Aug 14, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jun 27, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
May 06, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 02, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 11, 2024

Correspondence

Form CORRESP - Correspondence